Influence of Polyacrylic acid (PAA)/Na 2 HPO 4 mixture on biphasic calcium phosphate cement: Enhancing strength and cell viability

Author(s):  
Paritat Thaitalay ◽  
Oranich Thongsri ◽  
Rawee Dangviriyakul ◽  
Sawitri Srisuwan ◽  
Chutima Talabnin ◽  
...  
2016 ◽  
Vol 23 (1) ◽  
pp. 37-44 ◽  
Author(s):  
Weizhong Yang ◽  
Yong Yi ◽  
Yuan Ma ◽  
Li Zhang ◽  
Jianwen Gu ◽  
...  

AbstractNano biphasic calcium phosphate (BCP) particles were synthesized using the sol-gel method. As-prepared BCP particles were combined with poly-L-lactide (PLLA) to fabricate nano-BCP/PLLA composite scaffold through a series of processing steps containing solvent self-diffusion, hot-pressing, and particulate leaching. The composite had a suitable porous structure for bone tissue engineering scaffold. In comparison, micro-BCP/PLLA scaffold was studied as well. Nano-BCP particles were distributed homogeneously in the PLLA matrix, and much more tiny crystallites exposed on the surface of the pore wall. Due to the finer inorganic particle distribution in the PLLA phase and the larger area of the bioactive phase exposed in the pore wall surface, nano-BCP/PLLA scaffold had enhanced compressive strength, good bioactivity, and superior cell viability. A nonstoichiometric apatite layer could be rapidly formed on the surface of nano- BCP/PLLA when soaked in simulated body fluid. The MG-63 cell viability of nano-BCP/PLLA scaffold is significantly higher than that of micro-BCP/PLLA scaffold. Therefore, nano-BCP/PLLA composite may be a suitable alternative for bone tissue engineering scaffold.


Author(s):  
Nuan La Ong Srakaew ◽  
Sirirat Tubsungnoen Rattanachan

Self-setting calcium phosphate cement (CPC) has been used in bone repair and substitution due to their excellent biocompatibility, bioactive as well as simplicity of preparation and use. The inherent brittleness and slow degradation are the major disadvantages for the use of calcium phosphate cements. To improve the degradation for the traditional CPC, the apatite cement formula incorporated with β-tricalcium phosphate (β-TCP) with varying concentration were studied and the effect of the pH value of liquid phase on the properties of this new calcium phosphate cement formula was evaluated. The apatite cements containing β-TCP for 10 and 40 wt.% were mixed into the aqueous solution with different pH values and then aging in absolute humidity at 37°C for 7 days. The setting time and phase analysis of the biphasic calcium phosphate were determined as compared to the apatite cement. For proper medical application, the compressive strength, the phase analysis and the degradation of the CPC samples at pH 7.0 and 7.4 were evaluated after soaking in the simulated body fluid (SBF) at 37°C for 7 days. The results indicated that the properties of the samples such as the setting time, the compressive strength related to the phase analysis of the set cements. The high degradation of the CPC was found in the cement with increasing β-TCP addition due to the phase after setting. Apatite formation with oriented plate-like morphology was also found to be denser on the surface of the biphasic bone cements after soaking in SBF for 7 days. The obtained results indicated that the cement containing β-TCP mixed with the liquid phase at pH 7.4 could be considered as a highly biodegradable and bioactive bone cement, as compared to the traditional CPC.


2013 ◽  
Vol 2013 ◽  
pp. 1-9 ◽  
Author(s):  
Wen-Yu Su ◽  
Yu-Chun Chen ◽  
Feng-Huei Lin

Osteomyelitis therapy is a long-term and inconvenient procedure for a patient. Antibiotic-loaded bone cements are both a complementary and alternative treatment option to intravenous antibiotic therapy for the treatment of osteomyelitis. In the current study, the biphasic calcium phosphate cement (CPC), calledα-TCP/HAP (α-tricalcium phosphate/hydroxyapatite) biphasic cement, was prepared as an antibiotics carrier for osteomyelitis. The developed biphasic cement with a microstructure ofα-TCP surrounding the HAP has a fast setting time which will fulfill the clinical demand. The X-ray diffraction and Fourier transform infrared spectrometry analyses showed the final phase to be HAP, the basic bone mineral, after setting for a period of time. Scanning electron microscopy revealed a porous structure with particle sizes of a few micrometers. The addition of gentamicin inα-TCP/HAP would delay the transition ofα-TCP but would not change the final-phase HAP. The gentamicin-loadedα-TCP/HAP supplies high doses of the antibiotic during the initial 24 hours when they are soaked in phosphate buffer solution (PBS). Thereafter, a slower drug release is produced, supplying minimum inhibitory concentration until the end of the experiment (30 days). Studies of growth inhibition ofStaphylococcus aureusandPseudomonas aeruginosain culture indicated that gentamicin released after 30 days fromα-TCP/HAP biphasic cement retained antibacterial activity.


2008 ◽  
Vol 24 (12) ◽  
pp. 1616-1622 ◽  
Author(s):  
W CHEN ◽  
C JU ◽  
J WANG ◽  
C HUNG ◽  
J CHERNLIN

Nanomaterials ◽  
2021 ◽  
Vol 11 (3) ◽  
pp. 617
Author(s):  
Ji-Bong Choi ◽  
Yu-Kyoung Kim ◽  
Seon-Mi Byeon ◽  
Jung-Eun Park ◽  
Tae-Sung Bae ◽  
...  

In the field of bone tissue, maintaining adequate mechanical strength and tissue volume is an important part. Recently, biphasic calcium phosphate (BCP) was fabricated to solve the shortcomings of hydroxyapatite (HA) and beta-tricalcium phosphate (β-TCP), and it is widely studied in the field of bone-tissue engineering. In this study, a composite hydrogel was fabricated by applying BCP to gelatin methacrylate (GelMA). It was tested by using a mechanical tester, to characterize the mechanical properties of the prepared composite hydrogel. The fabricated BCP was analyzed through FTIR and XRD. As a result, a different characteristic pattern from hydroxyapatite (HA) and beta-tricalcium phosphate (β-TCP) was observed, and it was confirmed that it was successfully bound to the hydrogel. Then, the proliferation and differentiation of preosteoblasts were checked to evaluate cell viability. The analysis results showed high cell viability and relatively high bone differentiation ability in the composite hydrogel to which BCP was applied. These features have been shown to be beneficial for bone regeneration by maintaining the volume and shape of the hydrogel. In addition, hydrogels can be advantageous for clinical use, as they can shape the structure of the material for custom applications.


2021 ◽  
Vol 127 (12) ◽  
Author(s):  
Mostafa Mabrouk ◽  
Sahar M. Mousa ◽  
W. A. Abd ElGhany ◽  
Mahmoud T. Abo-elfadl ◽  
Gehan T. El-Bassyouni

2015 ◽  
Vol 749 ◽  
pp. 437-440 ◽  
Author(s):  
Chin Wei Chang ◽  
Chia Ling Ko ◽  
Ya Shun Chen ◽  
Jia Horng Lin ◽  
Wen Cheng Chen

This proposal aims to develop a newly, stable, excellent and environmental process of manufacturing scaffolds with virtually identical biphasic calcium phosphate compositions. Calcium phosphate cements (CPCs), which combines calcium orthophosphate powders with a liquid leading to a paste that hardens spontaneously at low temperatures, have potential to be used as a porous template for dental bone grafting substitutes [1,2]. Such newly developed sintering processes having the bone grafts with properties of bioactivity or even bioresorbability would be applied in many clinical setting. Template materials combine calcium orthophosphate powders with a liquid leading to a paste that hardens spontaneously at low temperatures. Hence, CPCs could be applied as scaffolds to support cell/tissue growth [3, 4]. This paper studies CPC scaffolds processing by foaming cement's paste state in which was added phasic stabilizer of magnesia and foaming agent of sucrose. The X-ray diffraction was performed to identify the phases of bone grafting substitutes, and we also used scanning electron microscope to observe the structure and pores of bone grafting substitutes. The cell viability about biocompatibility of developed bone grafting substitutes was examined. The results showed that our bone grafting substitutes produced steady final biphasic products consisting of hydroxyapatite (HA) and beta-tricalcium phosphates (β-TCP). We observed interconnected pores and highly porosity in microstructure of the bone grafting substitutes. The cell viability was over 70 % to make sure that the bone grafting substitutes has excellent biocompatibility. In conclusion, using the slurry of calcium phosphate cements (CPCs) and pores forming agent set into a porous template would be a useful process for manufacturing bone graft substitutes.


2007 ◽  
Vol 361-363 ◽  
pp. 411-414 ◽  
Author(s):  
Gaelle Jouan ◽  
Eric Goyenvalle ◽  
Eric Aguado ◽  
Ronan Cognet ◽  
Françoise Moreau ◽  
...  

Resorbable osteosynthesis based on PLLA and derivatives will be associated to bone substitute for bone reconstruction. We have performed rand evaluated a composite combining PL DLLA and Biphasic calcium phosphate able to have a), a better controlled hydrolysis in the purpose to preserve on time the mechanical property, and b), for long term efficiency, bone ingrowth at the expense of the osteosynthesis and the associated bone substitute. A new calcium phosphate cement MCPC® was tested with such composite. The novel macroporous calcium phosphate cement MCPC sets to poorly crystalline apatite after mixing the powder component and an aqueous solution. Interconnective macroporosity was induced on time by resorption of one part of the MCPC®. The multiphasic calcium phosphate components in the cement, are resorbed at different rates allowing the replacement by newly formed bone. This study reports the biocompatibility and the interactions of a composite using PL DLLA (Poly [L-Lactide-co-D,L-Lactide] acid) charged with biphasic calcium phosphate granules and a self setting calcium phosphate cement of new generation.


Sign in / Sign up

Export Citation Format

Share Document